Cargando…
Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100300/ http://dx.doi.org/10.1016/j.jbc.2023.104200 |
| _version_ | 1785025246856740864 |
|---|---|
| author | Olivier, Paul Mast, Fred Fridy, Peter Ketaren, Natalia Miller, Leslie Sanyal, Tanmoy Rout, Michael Chait, Brian Aitchison, John |
| author_facet | Olivier, Paul Mast, Fred Fridy, Peter Ketaren, Natalia Miller, Leslie Sanyal, Tanmoy Rout, Michael Chait, Brian Aitchison, John |
| author_sort | Olivier, Paul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10100300 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101003002023-04-13 Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice Olivier, Paul Mast, Fred Fridy, Peter Ketaren, Natalia Miller, Leslie Sanyal, Tanmoy Rout, Michael Chait, Brian Aitchison, John J Biol Chem In Vitro Reconstitution of Ribosome Biogenesis The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc. 2023 2023-04-13 /pmc/articles/PMC10100300/ http://dx.doi.org/10.1016/j.jbc.2023.104200 Text en Copyright © 2023 The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | In Vitro Reconstitution of Ribosome Biogenesis Olivier, Paul Mast, Fred Fridy, Peter Ketaren, Natalia Miller, Leslie Sanyal, Tanmoy Rout, Michael Chait, Brian Aitchison, John Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice |
| title | Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice |
| title_full | Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice |
| title_fullStr | Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice |
| title_full_unstemmed | Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice |
| title_short | Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice |
| title_sort | abstract 2702: highly synergistic combinations of nanobodies that target sars-cov-2 reduce viral load in hace2 transgenic mice |
| topic | In Vitro Reconstitution of Ribosome Biogenesis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100300/ http://dx.doi.org/10.1016/j.jbc.2023.104200 |
| work_keys_str_mv | AT olivierpaul abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT mastfred abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT fridypeter abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT ketarennatalia abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT millerleslie abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT sanyaltanmoy abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT routmichael abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT chaitbrian abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice AT aitchisonjohn abstract2702highlysynergisticcombinationsofnanobodiesthattargetsarscov2reduceviralloadinhace2transgenicmice |